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Abstract
Background: There is a current lack of consensus on defining metabolically healthy obesity (MHO). Limited data on
dietary and lifestyle factors and MHO exist. The aim of this study is to compare the prevalence, dietary factors and
lifestyle behaviours of metabolically healthy and unhealthy obese and non-obese subjects according to different
metabolic health criteria.
Method: Cross-sectional sample of 1,008 men and 1,039 women aged 45-74 years participated in the study.
Participants were classified as obese (BMI ≥30kg/m2) and non-obese (BMI <30kg/m2). Metabolic health status was
defined using five existing MH definitions based on a range of cardiometabolic abnormalities. Dietary composition
and quality, food pyramid servings, physical activity, alcohol and smoking behaviours were examined.
Results: The prevalence of MHO varied considerably between definitions (2.2% to 11.9%), was higher among
females and generally increased with age. Agreement between MHO classifications was poor. Among the obese,
prevalence of MH was 6.8% to 36.6%. Among the non-obese, prevalence of metabolically unhealthy subjects was
21.8% to 87%. Calorie intake, dietary macronutrient composition, physical activity, alcohol and smoking behaviours
were similar between the metabolically healthy and unhealthy regardless of BMI. Greater compliance with food
pyramid recommendations and higher dietary quality were positively associated with metabolic health in obese (OR
1.45-1.53 unadjusted model) and non-obese subjects (OR 1.37-1.39 unadjusted model), respectively. Physical
activity was associated with MHO defined by insulin resistance (OR 1.87, 95% CI 1.19-2.92, p = 0.006).
Conclusion: A standard MHO definition is required. Moderate and high levels of physical activity and compliance
with food pyramid recommendations increase the likelihood of MHO. Stratification of obese individuals based on their
metabolic health phenotype may be important in ascertaining the appropriate therapeutic or intervention strategy.
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Introduction
Obesity prevalence is increasing worldwide, with the
condition predicted to affect more than one billion people by
2030 [1]. Obesity is associated with increased risk of
developing co-morbidities including type 2 diabetes mellitus
(T2DM) and cardiovascular disease (CVD) [2,3], leading to
increased risk of premature death. Consistent with this are
recent data from a very large meta-analysis confirming
significantly higher all-cause mortality with obesity when all
grades are combined [4]. However grade 1 obesity (BMI 30 to
< 35 kg/m2) was not associated with higher mortality. It is
known that the obese phenotype may exist in the absence of
metabolic abnormalities such as dyslipidaemia, insulin
resistance and hypertension [5–7], which may partly explain
these conflicting findings. Likewise not all non-obese
individuals present a healthy metabolic and disease-free
profile. There has been much interest in the paradoxical finding
of individuals considered “metabolically healthy” despite
increased adiposity. Subsequently several phenotype
subgroups of obesity have been described including
metabolically healthy obese (MHO) [6–11].
Determinants of MHO are unclear, particularly regards
dietary and lifestyle behaviours [12,13]. Limited data on dietary
composition and MHO exist. Results from a recent examination
of dietary composition (food groups), macro- and micronutrient
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intakes and physical activity in a multi-ethnic group of 775
obese Americans do not support the hypothesis that dietary
composition or physical activity are associated with MH [14].
Despite the knowledge of the MHO phenotype for some time
now there are no unique criteria to define MH, resulting in
widely varying prevalence estimates (6-35%) depending on
which criteria are used [15,16]. No comparative data examining
both dietary composition/quality and physical activity using a
variety of MH definitions are currently available.
Current obesity treatment guidelines do not distinguish
between MHO and metabolically unhealthy obesity (MUO), and
recommend treatment for all obese individuals, starting with
lifestyle intervention [17]. While studies examining the impact of
dietary and exercise interventions in MHO are sparse and have
produced conflicting results [18–21], they highlight the potential
benefits of differentiating MHO and MUO individuals.
Stratification of obese individuals based on their metabolic
health phenotype may be important in determining the
appropriate therapeutic strategy. The main objectives of this
paper are to examine metabolic health prevalence in obese
and non-obese men and women across a range of definitions
and to comprehensively investigate to what extent differences
between metabolically healthy and unhealthy obese and non-
obese subjects are explained by dietary and lifestyle factors.
Materials and Methods
Study design and subject recruitment
The Cork and Kerry Diabetes and Heart Disease Study
(Phase II) was a single centre, cross-sectional study conducted
between 2010 and 2011 [22]. In brief, a population
representative random sample was recruited from a large
primary care centre in Mitchelstown, County Cork, Ireland
(Mitchelstown cohort). The Livinghealth Clinic includes 8
general practitioners and serves a catchment area of
approximately 20,000 with a mix of urban and rural residents.
Participants were randomly selected from all registered
attending patients in the 50-69 year age group. In total 3,807
potential participants were selected from the practice list.
Following exclusion of duplicates, deaths and ineligibles, 3,043
were invited to participate in the study and of these 2,047
(49.2% male) completed the questionnaire and physical
examination components of the assessment (response rate
67%). Ethics committee approval conforming to the Declaration
of Helsinki was obtained from the Clinical Research Ethics
Committee of University College Cork. All participants provided
written informed consent. Following exclusion of missing BMI
data the remaining 2,040 participants were analysed.
Clinical data
Participants attended the clinic in the morning after an
overnight fast (minimum 8h). Fasting blood samples were
taken on arrival. Participants completed a General Health
Questionnaire (GHQ), a Food Frequency Questionnaire (FFQ)
and the International Physical Activity Questionnaire (IPAQ).
Data on age, gender, family history, medication use (diabetes,
dyslipidaemia and hypertension) and medical history (diabetes,
hypertension and cardiovascular disease) was gathered
through a self-completed GHQ. Blood pressure was measured
according to the European Society of Hypertension Guidelines
using an Omron M7 Digital BP monitor on the right arm, after a
5 minute rest in the seated position. The average of the second
and third measurements was used for analyses.
Anthropometric data
Anthropometric measurements were recorded with calibrated
instruments according to a standardised protocol. Body weight
was measured in kilograms without shoes, to the nearest 100g,
using a Tanita WB100MA weighing scales (Tanita Corporation,
IL, USA). Height was measured in centimetres to 1 decimal
place using a Seca, Leicester height gauge (Seca,
Birmingham, UK). Waist circumference (defined as mid-way
between lowest rib and iliac crest) was measured in
centimetres to 1 decimal place using a Seca 200 measuring
tape (Seca, Birmingham, UK). The average of two measures
were used for analyses. Body mass index (BMI) was
calculated. Body fat percentage (BF%) was estimated using a
recently described body adiposity estimator [23]. Individuals
with a BMI ≥30kg/m2 were defined as obese.
Dietary and lifestyle data
Diet was assessed using a modified version of the self-
completed EPIC FFQ used in the Cork and Kerry Phase 1
study [24] which has been validated for use in the Irish
population. A dietary score (the DASH (Dietary Approaches to
Stop Hypertension) score) was calculated using the FFQ
responses. It was a composite score derived from standard
food groups within the FFQ as described by Fung et al. [25].
For each food group, consumption was divided into quintiles
and participants were classified according to their intake
ranking. Consumption of healthy food components were rated
on a scale of 1-5, the higher the score the more frequent the
consumption of that food. Less healthy dietary constituents,
where low consumption is desired, were scored on a reverse
scale with lower consumption receiving the higher scores.
Component scores were summed and an overall DASH score
for each person was calculated. A lower score indicated a
poorer dietary quality. The DASH score was also categorised
by median. Daily servings from each food pyramid shelf and
compliance with the food pyramid were also determined.
Physical activity levels were assessed using the short form
IPAQ [26] which provided information on frequency, duration
and intensity of physical activity. Physical activity was
categorized into 3 groups; low, moderate and high, based on a
combination of activity frequency, duration of each activity bout
and metabolic equivalent (MET) minutes per week in all activity
types. Subjects were additionally classified according to current
Irish physical activity guidelines of at least 30 minutes of
moderate exercise 5 days a week or 150 minutes per week.
Smoking status was defined as never, former and current
smokers. Alcohol consumption included questions based on
weekly intake to define never, moderate and heavy drinkers
[27]. The Alcohol Use Disorders Identification Test (AUDIT-C)
was used to identify subjects who are hazardous drinkers or
have active alcohol use disorders.
Metabolically Healthy Obesity, Diet and Lifestyle
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Biological analyses
Plasma and serum were prepared from fasting blood
samples from each subject. Fasting plasma glucose (FPG),
serum total, high density lipoprotein (HDL) cholesterol, low
density lipoprotein (LDL) cholesterol and triglycerides levels
were measured by Cork University Hospital Biochemistry
Laboratory using fresh blood samples. FPG concentrations
were determined using a glucose hexokinase assay and serum
lipids were analysed using enzymatic colorimetric tests
(Olympus Life and Material Science Europa Ltd., Lismeehan,
Co. Clare, Ireland) on an Olympus 5400 automatic analyser
(Olympus Diagnostica Gmbh, Hamburg, Germany). Serum
insulin and C reactive protein (CRP) were determined using a
biochip array system (Evidence Investigator; Randox
Laboratories, UK). Homeostasis model assessment of insulin
resistance (HOMA-IR) was derived from fasting glucose and
insulin concentrations as [(fasting plasma glucose x fasting
serum insulin)/ 22.5] [28].
Determination of metabolic health status
Subjects were classified according to their BMI as obese
(BMI ≥30kg/m2) and non-obese (BMI <30kg/m2). Metabolic
health status was defined using a selection of five existing MH
definitions based on a range of cardiometabolic abnormalities
[9,29–32] (Table 1). In secondary analyses we also examined
the combined overweight and obese (BMI ≥25kg/m2) subjects
and the normal weight only (BMI <25kg/m2) subjects generating
the following groups: metabolically healthy overweight and
obese (MHOWO), metabolically unhealthy overweight and
obese (MUOWO), metabolically healthy normal weight (MHN)
and metabolically unhealthy normal weight (MUN).
Statistical analysis
Statistical analysis was conducted using PASW Statistics
version 18.0 for Windows (SPSS Inc, Chicago, IL). Continuous
variables are expressed as means ± SEM and categorical
variables as percentages. Biochemical variables were
assessed for normality of distribution, and skewed variables
were normalised by log10 or square root transformation as
appropriate. Differences between groups were analysed by
independent t-tests for continuous variables and Chi-Square
test for categorical variables. Logistic regression was used to
determine associations between MHO and MHNO,
demographic, dietary and lifestyle factors. Multivariate logistic
regression analysis was performed including age, gender,
dietary quality, food pyramid compliance, physical activity,
smoking status and alcohol consumption as confounding
factors. Pair-wise comparison of agreement between metabolic
health definitions was assessed by Cohen’s kappa where
values >0.75, 0.4-0.75 and <0.4 indicate excellent, fair to good
and poor agreement, respectively [33]. A P-value of < 0.05 was
considered significant.
Results
Prevalence of metabolically healthy and unhealthy
obese and non-obese phenotypes
The proportion of individuals in the Mitchelstown cohort
defined as being metabolically healthy by BMI categories
varied considerably between definitions (Figure 1A). Among all
individuals, 2.2% to 11.9%, were obese yet metabolically
healthy (MHO), 20.6% to 30.1% were obese and metabolically
unhealthy (MUO), 14.7% to 59% were non-obese yet
metabolically unhealthy (MUNO), and 8.8% to 52.7% were
non-obese and metabolically healthy (MHNO). Among the
obese participants, the proportion of metabolically healthy
subjects ranged from 6.8% (Aguilar-Salinas), 14.2% (Karelis),
23.7% (Wildman), 30.2% (Meigs (A)) to 36.6% (Meigs B).
Among the non-obese participants, the proportion of
metabolically unhealthy subjects ranged from 21.8% (Meigs B),
32.4% (Meigs (A)), 41.7% (Wildman), 75.2% (Karelis) to 87%
Table 1. Criteria used to define metabolic health status.
 
Aguilar-
Salinas Karelis Meigs (A)1 Meigs (B)2 Wildman
Blood
pressure
SBP <140
and DBP
<90 or no
treatment
-
SBP ≥130
or DBP ≥85
or
treatment
-
SBP ≥130
or DBP ≥85
or treatment
TAG,
mmol/L - ≤1.70 ≥1.70 - ≥1.70
HDL-C,
mmol/L ≥1.04
≥1.30 and
no
treatment
<1.04 (M)
<1.30 (F) -
<1.04 (M)
<1.30 (F) or
treatment
LDL-C,
mmol/L -
≤2.60 and
no
treatment
- - -
Total-C,
mmol/L - ≥5.20 - - -
FPG,
mmol/L
<7.00 and
no
treatment
- ≥5.60 ortreatment -
≥5.55 or
treatment
HOMA  ≤1.95  <75
th
percentile3
>90th
percentile
Other - -
Waist
>102cm
(M)Waist
>88cm (F)
- CRP >90
th
percentile
MH criteria All of theabove
≥4 of the
above
<3 of the
above
All of the
above
<2 of the
above
Study
population
Mexico n =
716, 26.4%
male
Canada n
= 154, 0%
male
US n =
2902, 45%
male
US n =
2902, 45%
male
US n =
5440,
47.9% male
Abbreviations: DBP: diastolic blood pressure; F: female; FPG: fasting plasma
glucose; M: male; MH: metabolically healthy; SBP: systolic blood pressure. 1Using
metabolic syndrome variables. 2Using homeostasis model only. 3Among non-
diabetic subjects.
doi: 10.1371/journal.pone.0076188.t001
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(Aguilar-Salinas). Examination of metabolic health obese
phenotypes according to gender revealed higher prevalence of
metabolic health among both obese and non-obese females,
whereas the prevalence of the metabolically unhealthy
phenotype was generally greater among obese and non-obese
males (Figure 1B and 1C). MHO prevalence increased with
age, except for MHO defined by Aguilar-Salinas and Karelis
(Figure 2), whereas the prevalence of MHNO decreased with
age according to each definition. Secondary analysis of the
prevalence estimates of MHOWO, MUOWO, MHN and MUN
followed the same definition dependent trends identified in the
primary analysis (Table S1).
Agreement between MHO classifications
We examined whether the same individuals were classified
as MHO according to the different definitions. Comparison of
the four definitions which led to the greatest prevalence
(Karelis et al., Meigs et al., and Wildman et al.) revealed that
only 20 subjects were simultaneously classified as MHO
(Figure 3A). Examination of the Meigs et al., definitions
revealed some degree of concordance. These scores identified
a total of 436 MHO subjects: n=202 (Meigs A) and n=234
(Meigs B). Of the 234 participants classified as MHO according
to Meigs B, 44.4% were simultaneously classified as MHO by
Meigs A (Cohen’s kappa 0.23, p < 0.001) (Figure 3B).
Comparison of the three MH definitions which included HOMA
(Karelis et al., Meigs et al., (B) and Wildman et al.) identified
only 25 subjects being similarly classified as MHO (Figure 3C).
Anthropometric measures and clinical characteristics
Clinical and anthropometric characteristics of the study
population according to both metabolic health status and BMI
category are presented in Table 2. Compared to their
metabolically unhealthy counterparts both the MHNO and MHO
subjects had smaller waist circumference, lower BMI, TAG,
FPG and higher HDL-C concentrations, reduced insulin
resistance and were less hypertensive, with the exception of
the MHO subjects defined by Aguilar-Salinas. In the secondary
analyses comparison of the MHOWO and MUOWO subjects
mirrored these findings, whereas some definition dependent
differences were noted between the MHN and MUN subjects
(Table S2).
Dietary composition, quality and food pyramid shelf
servings
No differences in calorie consumption, macronutrient intake
and dietary quality were observed between MHO and MUO
subjects (Table 3), with the exception of MHO subjects defined
by Meigs A who had higher fat and lower carbohydrate intakes.
Some definition dependent differences were noted between
daily servings of fruit and vegetables, dairy, meats and fats
between MHO and MUO subjects. Compliance with the food
pyramid recommendations was greater among the MHO
subjects (Meigs A and Wildman). Among the non-obese
subjects (Table 4), calorie intake and dietary macronutrient
composition were similar, with the exception of MHNO defined
by Aguilar-Salinas. Dietary quality was higher among the
MHNO subjects defined by Karelis and Meigs B. Daily number
of servings of fruit and vegetables and dairy were higher
among the MHNO defined by Meigs A, Meigs B and Wildman.
Micronutrient intakes were examined. MHO subjects had lower
retinol intake (Aguilar-Salinas and Meigs B) and higher iodine
intake (Meigs A and Wildman) compared to the MUO subjects
(p < 0.05, data not shown). The secondary analyses did not
reveal any significant differences regards energy intake,
macronutrient composition and dietary quality between the
MHOWO and MUOWO subjects. Comparison of the MHN and
MUN subjects produced similar findings to comparison
between MHNO and MUNO subjects (data not shown).
Lifestyle behaviours: physical activity, smoking status
and alcohol consumption
Examination of lifestyle behaviours among the obese
subjects (Table 3) did not reveal any differences in level of
physical activity intensity, daily total time of physical activity
and whether subjects met current physical activity guidelines.
Differences in smoking status and alcohol consumption were
noted for MHO defined by Wildman, wherein fewer MHO
subjects were current smokers and engaged in hazardous
drinking. Among the non-obese subjects (Table 4), duration of
physical activity was higher among the MHNO subjects defined
by Meigs A. Physical activity level, smoking status and alcohol
consumption were not different between the MHNO and MUNO
subjects. In the secondary analyses examination of physical
activity measures, smoking behaviour and alcohol consumption
did not reveal any significant differences between the
metabolically healthy and unhealthy subjects, regardless of
BMI (data not shown).
Determinants of the metabolically healthy phenotype
Among both the obese and non-obese subjects, females
were more approximately 2-4 times more likely to be
metabolically healthy relative to males (Table 5). Associations
with age were conflicting. Among the obese subjects, greater
compliance with food pyramid recommendations was positively
associated with MH defined by Meigs A (OR 1.49, 95% CI
1.07-2.08, p = 0.018), Meigs B (OR 1.45, 95% CI 1.05-2.00, p
= 0.025) and Wildman (OR 1.53, 95% CI 1.07-2.19, p = 0.021)
in the unadjusted analyses only. In the adjusted analyses a
moderate to high level of physical activity was positively
associated with MHO defined by insulin resistance, particularly
among those with a high level of activity (OR 2.35, 95% CI
1.28-4.34, p = 0.006) relative to those with a low level of
physical activity. Odds of presenting with MHO defined by
Karelis were greater among alcohol drinkers.
Among the non-obese subjects, again in the unadjusted
analyses higher dietary quality was positively associated with
MH defined by Karelis (OR 1.39, 95% CI 1.04-1.84, p = 0.024)
and Meigs B (OR 1.37, 95% CI 1.00-1.87, p = 0.048). These
differences did not remain significant in the multivariate
adjusted analysis. No relationship was identified with tobacco
smoking or alcohol consumption. While physical activity was
positively associated with metabolic health defined by insulin
resistance and by Wildman, these did not reach statistical
significance. In the secondary adjusted analysis comparison of
the MHOWO and MUOWO subjects mirrored these findings,
Metabolically Healthy Obesity, Diet and Lifestyle
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Figure 1.  Prevalence of metabolically healthy and unhealthy obese and non-obese phenotypes in the Mitchelstown cohort
according to different metabolic health criteria among all subjects and stratified by gender.  Results are expressed as the
percentage of all subjects (A), female (B) and male (C) participants within each metabolic health definition. The metabolically
healthy non-obese (MHNO), metabolically unhealthy non-obese (MUNO), metabolically healthy obese (MHO) and metabolically
unhealthy obese (MUO) groups are depicted as white, dark grey, black bars and light grey bars, respectively.
doi: 10.1371/journal.pone.0076188.g001
Metabolically Healthy Obesity, Diet and Lifestyle
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particularly with regard to the positive associations between
being female (for most definitions) and having a moderate to
high level of physical activity with metabolic health defined by
insulin resistance among the overweight and obese subjects
(Table S3).
Discussion
In this study we demonstrated considerable variation in the
prevalence of MHO (2.2% to 11.9%), MHNO (8.8% to 52.7%),
MUO (20.6% to 30.1%) and MUNO (14.7% to 59%).
Agreement between MHO classifications was poor. Among the
obese participants, the proportion of metabolically healthy
subjects ranged from 6.8% by Aguilar-Salinas, 14.2% by
Karelis, 23.7% by Wildman, 30.2% by Meigs (A) to 36.6% by
Meigs B. Two recent studies examined the prevalence of MHO
using a range of definitions [16,34]. Velho et al., reported MHO
prevalence among male and female obese subjects of
25.1-35.3% by Aguilar-Salinas, 3.3-11.4% by Karelis,
15.8-21.9% by Wildman, 30.1-39.0% by Meigs (A) and
32.1-43.3% by Meigs B [16]. The Korean study of 186 male
MHO subjects reported MHO prevalence among obese
subjects of 24.2% by Meigs B, 28.5% by Karelis and 59.7% by
Wildman [34]. Despite study design and population differences,
all three comparative studies indicate that MHO prevalence
differs considerably depending on which definition is used,
making comparisons between studies difficult.
Prevalence of metabolic health was higher among both
obese and non-obese females, in keeping with Velho et al.
[16]. Increasing age was associated with higher prevalence of
MHO defined by Karelis, Meigs A and Wildman, whereas
prevalence of MHO defined by Aguilar-Salinas and Meigs B
decreased with increasing age. Velho et al. [16], reported
decreased MHO prevalence with age in both genders, whereas
Yoo et al. [34], did not observe any age related differences,
probably due to the younger and narrow age range of study
participants (mean age 37 years). Whether MHO transitions to
MUO over time is unclear, but it may account for the observed
Figure 2.  Prevalence of metabolically healthy and unhealthy obese and non-obese phenotypes according to different
criteria stratified by age group.  The prevalence of metabolically healthy non-obese subjects (A) decreased with age according to
each definition. Conversely estimates of metabolically unhealthy non-obese subjects (B) increased with age according to each
definition. Metabolically healthy obesity (C) prevalence differed according to which definition was used. The Aguilar-Salinas et al.,
and Karelis et al., definitions identified the highest prevalence among the 45-54 yr olds whereas the Wildman et al., and Meigs et al.,
definitions found the greatest prevalence of MHO among the 65-74 yr olds. Prevalence of metabolically unhealthy obesity (D) was
consistently highest among the 55-64 yr olds, with the exception of the Aguilar-Salinas et al., definition. Meigs A is defined using
metabolic syndrome variables and Meigs B is defined using HOMA. Results are expressed as percentage of all subjects within each
age category. The 45-54, 55-64 and 65-74 yr old age groups are depicted as white, grey and black bars, respectively.
doi: 10.1371/journal.pone.0076188.g002
Metabolically Healthy Obesity, Diet and Lifestyle
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decreasing MHO prevalence with age. Regards metabolic
characteristics, the MHO and MHNO subjects had lower BMI,
smaller waist circumference, reduced insulin resistance, lower
glucose concentrations, more favourable lipid profiles and
blood pressure compared to their metabolically unhealthy
counterparts. Interestingly estimated body fat percentage was
not generally different between the MHO and MHNO subjects
and their metabolically unhealthy counterparts.
Dietary and lifestyle factors play an important role in the
development of insulin resistance, obesity, metabolic syndrome
and T2DM [35,36]. Increased consumption of high-energy, high
fat diets and deterioration in dietary quality coupled with
increased sedentary behaviour, result in increased
accumulation of adipose tissue and progression to overt
obesity, which is associated with insulin resistance, low-grade
inflammation and increased risk of associated cardiometabolic
abnormalities [37]. The exact molecular mechanisms
underlying the loss of optimal adipose functionality and insulin
resistance observed with increasing obesity are unclear. No
comparative data examining dietary composition, dietary
quality and lifestyle behaviours using a range of MH definitions
in male and female obese and non-obese adults exist. In our
study total calorie intake and dietary macronutrient composition
were similar between the metabolically healthy and unhealthy
regardless of BMI, with the exception of MHO subjects defined
by Meigs A who consumed more fat and less carbohydrate
than the MUO subjects. Data from two American studies do not
support the hypothesis that total energy or dietary
macronutrient intakes are associated with MHO [14,38]. The
Korean NHANES III analysed dietary patterns in metabolically
obese normal weight (MONW) and reported that high
carbohydrate intake, particularly of high carbohydrate snacks,
was associated with higher prevalence of MONW in women,
whereas a high protein diet reduced risk of MONW [39].
Unfortunately this study did not examine obese subjects. In the
present work dietary quality was not different between MHO
and MUO subjects, but was higher among MHNO subjects
defined by Karelis and Meigs B, and was positively associated
with MHNO in the unadjusted analyses. Better compliance with
food pyramid recommendations observed among the MHO
subjects (defined by HOMA and Wildman) was positively
associated with MHO in the unadjusted logistic analyses only.
Some differences were noted between number of daily
servings of fruit and vegetables, dairy, meats, fats and high fat/
sugar food and drinks between MHO and MUO subjects,
depending on which criteria are used. Only one earlier study
examined food groups in MHO and did not report any
differences [14]. The Finnish Type 2 Diabetes (FIN D2D)
survey examined fruit and vegetable intake and did not identify
differences between individuals with or without the metabolic
syndrome according to BMI category [40]. The diversity of our
results highlights the need for consensus regarding MHO
definition in order to develop targeted dietary approaches.
Physical activity is associated with health-related benefits
leading to lower risk of obesity, CVD and T2DM [41–43]. In our
study the level of physical activity intensity, daily total time of
physical activity and proportion of subjects meeting current
Irish physical activity guidelines were not different between
MHO and MUO subjects. The FIN D2D survey reported similar
amount of leisure time physical activity between obese men
and women with or without the metabolic syndrome [40]. Yoo
et al. [34], reported that male MHO subjects defined by HOMA
(Meigs B) were more regular exercisers, consistent with Velho
et al. [16]. We demonstrated that a moderate to high level of
physical activity was positively associated with MHO and also
MHOWO defined by HOMA. Leisure time physical activity was
also associated with MHO in the NHANES 1999-2004 cohort
[7], a finding that was replicated by Velho et al. [16].
Collectively these data suggest that the beneficial effects of
physical activity on cardiometabolic risk factors are evident
Figure 3.  Agreement between MHO definitions.  Only 20 subjects were simultaneously classified as MHO according to the four
definitions which led to the greatest prevalence (Figure 3A). Less than half (44.4%) of the MHO subjects identified by Meigs B were
simultaneously classified by Meigs A (Cohen’s kappa 0.23, p < 0.001) (Figure 3B). Comparison of the three MH definitions including
HOMA identified only 25 subjects being similarly classified as MHO (Figure 3C).
doi: 10.1371/journal.pone.0076188.g003
Metabolically Healthy Obesity, Diet and Lifestyle
PLOS ONE | www.plosone.org 7 October 2013 | Volume 8 | Issue 10 | e76188
even among overweight and obese subjects. No differences in
smoking status and alcohol consumption were observed
between the MHNO and MUNO subjects, whereas fewer MHO
subjects defined by Wildman were current smokers. Previous
studies have produced conflicting results regards metabolic
health and smoking [16,44] and alcohol consumption [7,16]. In
the adjusted analyses alcohol drinkers had increased odds for
presenting with MHO defined by Karelis. The beneficial effects
of moderate alcohol consumption on HDL-C are well known,
but detrimental effects of alcohol include raised triglyceride
concentrations, insulin resistance and abdominal obesity,
which may partly account for the lack of a relationship between
alcohol and MHO.
Our study has several strengths including a high participation
rate (67%) and inclusion of questionnaires to assess dietary
and lifestyle behaviours. Notwithstanding these strengths some
limitations can be identified. The cross-sectional study design
limited our ability to make an inference about the causal
Table 2. Anthropometric and clinical characteristics of the Mitchelstown cohort according to metabolic health by BMI
category.
  Aguilar-Salinas P Karelis P Meigs (A)1 P Meigs (B)2 P Wildman P
Age, yrs MHO 58.9±0.8  61.5±0.5  59.3±0.4  60.1±0.3  59.9±0.5  
 MUO 59.9±0.2 0.21 59.9±0.2 0.007 60.4±0.2 0.01 59.9±0.3 0.74 60.1±0.2 0.79
 MHNO 59.7±0.4  60.4±0.3  58.7±0.2  59.4±0.2  58.5±0.2  
 MUNO 59.6±0.2 0.72 59.3±0.2 0.002 61.4±0.2 0.000 60.5±0.3 0.004 61.1±0.2 0.000
BMI, kg/m2 MHO 33.0±0.5  33.3±0.3  32.9±0.2  32.8±0.2  32.7±0.2  
 MUO 34.0±0.1 0.06 34.0±0.1 0.000 34.2±0.1 0.000 34.3±0.2 0.000 34.2±0.2 0.000
 MHNO 25.9±0.2  25.7±0.1  25.6±0.1  25.6±0.1  25.6±0.1  
 MUNO 26.1±0.1 0.003 26.2±0.1 0.000 27.0±0.1 0.000 27.6±0.1 0.000 26.8±0.1 0.000
Waist, cm MHO 106.2±1.5  105.5±1.0  105.9±0.7  104.9±0.6  105.4±0.8  
 MUO 109.2±0.4 0.09 109.8±0.4 0.07 110.6±0.5 0.000 111.3±0.5 0.000 110.4±0.5 0.000
 MHNO 89.1±0.7  89.0±0.5  89.3±0.3  89.5±0.3  89.0±0.3  
 MUNO 91.3±0.3 0.29 91.8±0.3 0.004 94.9±0.5 0.000 96.6±0.5 0.000 93.9±0.4 0.000
Body fat, % MHO 41.2±1.1  43.1±0.7  40.9±0.5  41.7±0.4  41.1±0.1  
 MUO 41.3±0.3 0.88 40.9±0.3 0.003 41.4±0.3 0.38 41.0±0.3 0.26 41.3±0.3 0.68
 MHNO 33.9±0.5  34.4±0.4  33.1±0.2  33.6±0.2  33.6±0.2  
 MUNO 33.7±0.2 0.70 33.5±0.2 0.02 34.9±0.3 0.000 34.1±0.4 0.22 33.9±0.3 0.39
TG, mmol/L MHO 1.43±0.0  1.13±0.04  1.17±0.03  1.39±0.04  1.15±0.03 0.000
 MUO 1.65±0.03 0.03 1.74±0.04 0.000 1.86±0.05 0.000 1.79±0.05 0.000 1.79±0.04 0.000
 MHNO 1.20±0.03  0.96±0.02  1.13±0.02  1.17±0.02  1.06±0.02  
 MUNO 1.30±0.02 0.000 1.40±0.03 0.000 1.61±0.05 0.000 1.74±0.06 0.000 1.61±0.04 0.000
HDL-C, mmol/L MHO 1.36±0.03  1.52±0.03  1.45±0.0  1.41±0.02  1.45±0.02  
 MUO 1.30±0.01 0.09 1.26±0.01 0.000 1.23±0.02 0.000 1.24±0.02 0.000 1.25±0.02 0.000
 MHNO 1.58±0.02  1.60±0.02  1.56±0.01  1.57±0.01  1.61±0.01  
 MUNO 1.52±0.01 0.03 1.50±0.01 0.000 1.43±0.02 0.000 1.33±0.02 0.000 1.40±0.02 0.000
FPG, mmol/L MHO 5.20±0.09  5.27±0.13  4.96±0.03  5.01±0.04  4.87±0.03  
 MUO 5.53±0.06 0.006 5.58±0.07 0.03 5.78±0.08 0.000 5.87±0.09 0.000 5.73±0.07 0.000
 MHNO 4.86±0.05  4.92±0.04  4.85±0.02  4.85±0.02  4.78±0.02  
 MUNO 5.05±0.03 0.000 5.08±0.03 0.003 5.42±0.07 0.000 5.73±0.10 0.000 5.39±0.06 0.000
HOMA MHO 3.71±0.65  2.81±0.37  3.02±0.17  1.66±0.04  2.21±0.13  
 MUO 4.65±0.19 0.17 4.93±0.20 0.000 5.33±0.24 0.000 6.33±0.25 0.000 5.35±0.22 0.000
 MHNO 1.74±0.09  1.57±0.08  1.60±0.03  1.34±0.02  1.41±0.03  
 MUNO 2.04±0.06 0.004 2.15±0.06 0.000 2.84±0.13 0.000 4.37±0.15 0.000 2.81±0.10 0.000
SBP, mm Hg MHO 124.3±1.4  133.0±1.7  130.6±1.2  132.4±1.1  128.4±1.4  
 MUO 134.4±0.7 0.000 133.7±0.7 0.68 134.9±0.7 0.002 134.1±0.8 0.23 135.2±0.7 0.000
 MHNO 119.9±0.8  127.1±0.9  124.3±0.5  126.7±0.5  122.6±0.5  
 MUNO 128.8±0.5 0.000 127.9±0.5 0.43 134.5±0.8 0.000 132.2±0.9 0.000 134.8±0.7 0.000
DBP, mm Hg MHO 78.1±1.1  80.5±0.9  81.7±0.7  82.1±0.6  80.3±0.8  
 MUO 82.9±0.4 0.000 81.8±0.4 0.04 82.8±0.4 0.19 82.7±0.5 0.43 83.2±0.4 0.002
 MHNO 75.2±0.5  77.4±0.5  77.6±0.3  78.4±0.3  76.8±0.3  
 MUNO 79.5±0.3 0.000 79.5±0.3 0.000 81.9±0.5 0.000 81.6±0.5 0.000 82.0±0.4 0.000
1Values are presented as means ± SEM. 2Statistical analysis conducted using Students t-tests. The first p value represents the metabolically healthy non-obese vs
metabolically unhealthy non-obese comparison. The second p value represents the metabolically healthy obese vs metabolically unhealthy obese comparison.
doi: 10.1371/journal.pone.0076188.t002
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relationships between dietary and lifestyle factors and MHO.
The use of self-reported questionnaires are subject to potential
inaccuracies, recall and reporting biases. BMI was used to
classify subjects as obese. As BMI does not discriminate
between lean and fat body mass, persons of short stature or
muscular build may be misclassified. Future work may benefit
from direct measurement of body fat using dual-energy X-ray
absorptiometry (DEXA). Prospective studies tracking the
development of cardiometabolic disease and mortality in MHO
are required. The planned longitudinal follow-up of the
Mitchelstown cohort will allow differences in disease
incidences, transition from MHO to MUO, and all-cause
mortality risk according to the different MH criteria to be
ascertained.
Our findings could have important clinical and public health
nutrition significance. There is a clear need to improve obesity
diagnosis, particularly of obese subjects at greatest
cardiometabolic risk, and to develop new preventative and
therapeutic strategies and evidence based public health
measures to attenuate disease development and reduce the
significant economic cost of obesity. We have shown that
assessing body fat percentage (BF%) and BMI to classify
obesity may help identify individuals at greater cardiometabolic
risk than BMI alone [45]. Those identified as obese using both
tools had a more metabolically unhealthy profile and were not
responsive to dietary intervention. Furthermore we have
recently demonstrated that favourable inflammatory status is
positively associated with metabolic health in obese and non-
obese individuals [46]. Taken collectively these findings
Table 3. Dietary and lifestyle factors according to metabolic health status among the obese Mitchelstown cohort participants.
 Aguilar-Salinas  Karelis  Meigs (A)1  Meigs (B)2  Wildman  
 MHO MUO MHO MUO MHO MUO MHO MUO MHO MUO
 n = 42 n = 574 n = 95 n = 573 n = 202 n = 466 n = 234 n = 405 n = 158 n = 510
Dietary composition and quality           
Kilocalories 2224±172 2039±32 2152±97 2042±33 1970±52 2096±39 2059±55 2060±40 1984±59 2080±37
Fat (% EI) 34.5±0.9 34.1±0.3 34.5±0.7 34.0±0.3 34.9±0.5* 33.7±0.2 34.1±0.5 34.1±0.3 35.0±0.6 33.8±0.3
Carbohydrate (% EI) 47.7±1.4 48.8±0.3 48.2±0.9 48.8±0.3 47.6±0.6* 49.1±0.4 48.6±0.6 48.9±0.4 47.8±0.7 48.9±0.4
Protein (% EI) 19.6±0.6 18.5±0.2 18.3±0.4 18.6±0.2 18.6±0.3 18.6±0.3 18.2±0.3 18.8±0.2 18.4±0.3 18.6±0.2
Fibre (% EI) 2.57±0.11 2.58±0.03 2.52±0.07 2.56±0.03 2.46±0.06 2.60±0.03 2.55±0.05 2.57±0.04 2.48±0.06 2.58±0.03
Sugar (% EI) 19.5±1.3 20.6±0.3 19.8±0.9 20.7±0.3 20.5±0.6 20.6±0.3 20.8±0.5 20.5±0.4 20.5±0.6 20.6±0.3
Dietary quality 26.9±1.3 28.5±0.3 29.4±0.7 28.3±0.3 28.5±0.3 28.4±0.3 28.4±0.4 28.4±0.3 28.4±0.5 28.4±0.3
Daily food pyramid shelf servings           
Bread, cereal, potatoes, grain and rice 4.6±0.4 5.2±0.1 5.5±0.4 5.1±0.1 5.3±0.2 5.1±0.1 5.4±0.2 5.0±0.1 5.5±0.2 5.0±0.1
Fruit and vegetable 5.3±0.6** 7.2±0.2 6.8±0.4 7.0±0.2 7.7±0.4* 6.7±0.2 7.3±0.4 6.8±0.2 7.6±0.4 6.8±0.2
Dairy 1.8±0.2 1.9±0.1 2.3±0.2* 1.9±0.1 2.0±0.1 1.9±0.1 1.9±0.1 1.9±0.1 2.0±0.1 1.9±0.1
Meat, fish, poultry, eggs 2.0±0.2** 2.5±0.1 2.5±0.2 2.5±0.1 2.5±0.1 2.5±0.1 2.5±0.1 2.5±0.1 2.6±0.1 2.4±0.1
Fats and high fat/sugar foods and drinks 8.3±0.9 7.9±0.2 7.8±0.6 8.0±0.2 8.5±0.4 7.7±0.2 8.0±0.4 7.9±0.3 8.8±0.5* 7.7±0.2
Food pyramid compliance 2.6±0.2 2.4±0.1 2.5±0.1 2.4±0.1 2.5±0.1* 2.3±0.1 2.5±0.1 2.3±0.1 2.5±0.01* 2.4±0.1
Physical activity (%)           
Low activity 54.2 61.5 55.2 48.9 55.4 51.9 59.1 47.7 55.3 51.0
Moderate activity 28.6 23.1 26.8 35.9 27.9 28.6 25.6 31.4 27.3 30.9
High activity 17.2 15.4 18.0 15.2 16.7 19.6 15.3 20.9 17.4 18.1
Meeting activity recommendations 6.1 19.0 17.7 18.8 18.3 18.8 15.0 20.3 14.9 19.8
Total PA (mins/day)3 83±25.6 117±9.1 111±20.6 119±9.3 115±13.1 119±10.8 126±13.0 113±12.0 108±14.2 121 ±10.2
Smoking status (%)           
Never smoker 48.8 49.9 46.2 49.6 51.0 48.3 50.7 48.6 47.7 49.6
Former smoker 34.1 40.5 45.1 39.9 41.8 40.1 40.3 40.2 47.1* 38.6
Current smoker 17.1 9.6 8.7 10.5 7.1 11.6 9.0 11.2 5.2 11.8
Alcohol intake (%)           
Non-drinker 13.6 24.3 24.4 24.4 20.9 24.2 24.1 23.0 22.8 23.3
Moderate drinker 68.2 61.9 67.2 61.5 65.9 60.7 62.1 61.9 66.3 61.0
Heavy drinker 18.2 13.8 16.4 14.2 13.2 15.1 13.8 15.1 10.9 15.7
Hazardous drinker 77.8 71.0 75.0 71.1 67.9 73.3 67.7 74.7 62.1* 74.6
Within recommendations 90.9 93.2 90.2 93.2 94.6 91.9 91 .0 93.3 93.1 92.7
1Using metabolic syndrome variables. 2Using homeostasis model only. 3Daily physical activity duration based on a typical day of activity. Abbreviations: PA Physical activity.
Values for continuous variables are presented as means ± SEM and categorical variables are presented as percentages. Statistical analysis conducted using Students t-test
for continuous variables and Chi-Square test for categorical variables. * represents P < 0.05 compared to MUO obtained using t-tests. ** represents P < 0.01 compared to
MUO obtained using t-tests.
doi: 10.1371/journal.pone.0076188.t003
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suggest that coordination of the pathways involved in nutrient
handling, insulin signalling, inflammation and lipid metabolism
is less disturbed in MHO and that the MUO subjects are simply
metabolically overburdened, and thus no longer dietary
responsive. Therefore stratification of obese individuals based
on their metabolic health phenotype may be important not only
in identification of individuals at greatest risk but also in
ascertaining the appropriate therapeutic or intervention
strategy.
In conclusion, our data suggest that physical activity and
compliance with food pyramid recommendations increase the
likelihood of MHO. The wide variation in the estimates of MHO
and MUNO observed in the current work underscore the need
for a single standard definition.
Table 4. Dietary and lifestyle factors according to metabolic health status among the non-obese Mitchelstown cohort
participants.
 Aguilar-Salinas  Karelis  Meigs (A)1  Meigs (B)2  Wildman  
 MHNO MUNO MHNO MUNO MHNO MUNO MHNO MUNO MHNO MUNO
 n = 168 n = 1126 n = 340 n = 1032 n = 928 n = 444 n = 1036 n = 289 n = 800 n = 572
Dietary composition and quality           
Kilocalories 2220±73 * 2000±24 2092±44 2000±26 2015±28 2035±38 2042±26 1974±46 2030±31 2010±33
Fat (% EI) 32.6±0.6 ** 33.8±0.2 34.0±0.4 33.4±0.2 33.5±0.2 33.6±0.2 33.7±0.2 33.2±0.4 33.7±0.3 33.4±0.3
Carbohydrate (% EI) 51.5±0.7 * 48.7±0.3 49.0±0.5 49.2±0.3 49.3±0.3 48.8±0.4 49.0±0.3 49.7±0.5 49.2±0.3 49.1±0.4
Protein (% EI) 17.9±0.3 ** 18.6±0.1 18.6±0.2 18.5±0.1 18.6±0.1 18.5±0.1 18.6±0.1 18.2±0.2 18.5±0.2 18.6±0.4
Fibre (% EI) 2.74±0.6 2.59±0.02 2.57±0.4 2.62±0.02 2.62±0.02 2.58±0.04 2.60±0.02 2.65±0.05 2.61±0.03 2.61±0.03
Sugar (% EI) 22.2±0.7 * 20.5±0.2 20.6±0.4 20.9±0.3 20.9±0.3 20.4±0.4 20.7±0.2 21.2±0.4 20.9±0.3 20.7±0.3
Dietary quality3 28.9±0.6 29.1±0.2 29.8±0.4 ** 28.8±0.2 29.1±0.2 29.1±0.3 29.2±0.2 ** 28.2±0.4 29.2±0.2 28.8±0.3
Daily food pyramid shelf servings           
Bread, cereal, potatoes, grain and rice 5.3±0.3 5.3±0.1 5.3±0.2 5.3±0.1 5.4±0.1 5.1±0.1 5.3±0.1 5.2±0.2 5.4±0.1 5.2±0.1
Fruit and vegetable 7.5±0.6 7.2±0.1 7.5±0.3 7.1±0.2 7.4±0.2 6.9±0.2 7.4±0.2 * 6.5±0.3 7.6±0.2 * 6.7±0.2
Dairy 1.9±0.1 2.0±0.1 2.0±0.1 1.9±0.1 2.0±0.1 * 1.8±0.1 2.0±0.1 * 1.7±0.1 2.1±0.1 * 1.8±0.1
Meat, fish, poultry, eggs 2.4±0.1 2.4±0.1 2.3±0.1 2.4±0.1 2.4±0.1 2.3±0.1 2.4±0.1 2.4±0.1 2.4±0.1 2.3±0.1
Fats and high fat/sugar foods and drinks 7.5±0.4 7.9±0.2 7.6±0.3 8.0±0.2 8.0±0.2 7.6±0.2 7.9±0.2 7.8±0.3 8.0±0.2 7.7±0.2
Food pyramid compliance 2.4±0.1 2.4±0.1 2.4±0.1 2.3±0.1 2.3±0.1 2.4±0.1 2.4±0.1 2.3±0.1 2.3±0.1 2.4±0.1
Physical activity (%)           
Low activity 45.8 43.6 46.4 43.8 47.8 44.7 48.5 45.0 49.2 43.3
Moderate activity 30.3 31.4 30.6 29.0 29.3 30.6 32.1 30.0 25.7 33.4
High activity 23.9 25.0 23.0 27.2 22.9 24.6 19.4 25.0 25.1 23.3
Meeting activity recommendations 21.7 19.9 19.0 20.5 22.2 16.0 20.1 19.8 21.1 18.8
Total PA (mins/day)3 158±20.6 143±7.4 141±11.8 146±8.1 157±9.0** 121±9.3 143±7.4 156±12.7 149±0.0 140 ±10.0
Smoking status (%)           
Never smoker 61.3 51.3 56.7 51.0 53.7 49.8 53.1 51.6 54.3 49.9
Former smoker 24.5 31.6 27.3 31.8 29.7 32.7 29.6 34.5 29.1 32.8
Current smoker 14.1 17.1 16.1 17.2 16.6 17.5 17.1 13.9 16.6 17.3
Alcohol intake (%)           
Non-drinker 14.3 19.6 20.6 18.1 19.2 17.6 18.3 19.7 18.8 18.6
Moderate drinker 76.2 65.3 66.1 66.5 66.4 66.4 67.2 64.1 68.3 63.8
Heavy drinker 9.5 15.1 13.3 15.4 14.1 15.9 14.5 16.2 12.9 17.6
Hazardous drinker 67.5 69.9 65.1 71.0 69.2 70.4 69.2 72.4 68.5 71.0
Within recommendations 90.5 90.3 89.9 89.9 90.0 89.5 90.3 88.9 90.5 89.0
1Using metabolic syndrome variables. 2Using homeostasis model only. 3Daily physical activity duration based on a typical day of activity. Abbreviations: PA Physical activity.
Values for continuous variables are presented as means ± SEM and categorical variables are presented as percentages. Statistical analysis conducted using Students t-test
for continuous variables and Chi-Square test for categorical variables. * represents P < 0.05 compared to MUNO obtained using t-tests. ** represents P < 0.01 compared to
MUNO obtained using t-test.
doi: 10.1371/journal.pone.0076188.t004
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Table 5. Multivariate-adjusted odds ratios for the metabolically healthy phenotype associated with demographic and lifestyle
factors among obese and non-obese individuals.
 Aguilar-Salinas  Karelis  Meigs (A)1  Meigs (B)2  Wildman  
Gender  P  P  P  P  P
Male 1 [reference]  1 [reference]  1 [reference]  1 [reference]  1 [reference]  
Female (obese) 0.60 (0.18-2.10) 0.43 3.85 (1.87-7.95) 0.000 2.02 (1.20-3.41) 0.008 2.69 (1.57-4.60) 0.000 2.99 (1.68-5.32) 0.000
Female (non-obese) 1.15 (0.68-1.94) 0.59 1.94 (1.32-2.84) 0.001 1.33 (0.94-1.90) 0.11 2.16 (1.45-3.23) 0.000 2.02 (1.44-2.84) 0.000
Age group           
45-54 1 [reference]  1 [reference]  1 [reference]  1 [reference]  1 [reference]  
55-64 (obese) 0.59 (0.20-1.84) 0.38 3.15 (1.20-8.30) 0.02 0.60 (0.34-1.08) 0.08 0.50 (0.28-0.90) 0.02 0.76 (0.40-1.42) 0.39
65-74 (obese) 0.32 (0.04-3.20) 0.30 4.80 (1.56-14.80) 0.006 0.59 (0.27-1.29) 0.18 1.30 (0.60-2.81) 0.50 0.85 (0.37-1.98) 0.71
55-64 (non-obese) 1.35 (0.76-2.40) 0.31 1.11 (0.73-1.70) 0.61 0.54 (0.36-0.81) 0.003 0.82 (0.53-1.27) 0.82 0.51 (0.35-0.75) 0.001
65-74 (non-obese) 0.88 (0.37-2.12) 0.78 1.82 (1.05-3.10) 0.03 0.25 (0.15-0.41) 0.000 0.70 (0.40-1.25) 0.70 0.28 (0.17-0.47) 0.000
Dietary quality3           
Low 1 [reference]  1 [reference]  1 [reference]  1 [reference]  1 [reference]  
High (obese) 0.76 (0.22-2.66) 0.67 1.41 (0.70-2.86) 0.34 1.21 (0.71-2.04) 0.48 1.21 (0.70-2.07) 0.50 1.00 (0.56-1.78) 0.99
High (non-obese) 0.79 (0.47-1.33) 0.38 1.17 (0.80-1.70) 0.43 0.97 (0.68-1.37) 0.85 1.13 (0.76-1.67) 0.55 0.93 (0.67-1.30) 0.67
Food pyramid compliance4           
Low 1 [reference]  1 [reference]  1 [reference]  1 [reference]  1 [reference]  
High (obese) 1.04 (0.33-3.20) 0.94 0.83 (0.42-1.65) 0.59 0.99 (0.60-1.65) 0.97 0.96 (0.57-1.62) 0.88 1.05 (0.60-1.83) 0.85
High (non-obese) 0.95 (0.57-1.57) 0.83 1.10 (0.77-1.59) 0.59 0.79 (0.49-1.37) 0.40 0.87 (0.59-1.27) 0.47 0.76 (0.55-1.05) 0.09
Physical activity           
Low 1 [reference]  1 [reference]  1 [reference]  1 [reference]  1 [reference]  
Moderate + High (obese) 0.87 (0.28-2.72) 0.80 1.09 (0.55-2.16) 0.81 1.23 (0.73-2.04) 0.44 1.77 (1.19-3.01) 0.002 1.34 (0.76-2.34) 0.30
Moderate + High (non-obese) 0.69 (0.42-1.15) 0.16 1.30 (0.89-1.89) 0.17 1.02 (0.91-1.44) 0.91 1.31 (0.89-1.93) 0.16 1.24 (0.89-1.73) 0.19
Smoking           
Never + Former 1 [reference]  1 [reference]  1 [reference]  1 [reference]  1 [reference]  
Current (obese) 2.17 (0.54-8.72) 0.28 0.74 (0.20-2.71) 0.65 0.42 (0.16-1.08) 0.07 0.89 (0.38-2.08) 0.80 0.36 (0.12-1.16) 0.07
Current (non-obese) 0.77 (0.46-1.77) 0.90 1.07 (0.66-1.74) 0.77 0.95 (0.61-1.49) 0.83 1.71 (0.97-3.00) 0.06 0.89 (0.58-1.37) 0.59
Alcohol intake           
Non-drinker 1 [reference]  1 [reference]  1 [reference]  1 [reference]  1 [reference]  
Drinker (obese) 1.48 (0.41-5.34) 0.55 2.81 (1.12-7.02) 0.027 1.49 (0.79-2.81) 0.21 1.53 (0.81-2.89) 0.19 1.51 (0.75-2.99) 0.24
Drinker (non-obese) 1.55 (0.76-3.13) 0.22 0.96 (0.61-1.50) 0.85 1.10 (0.73-1.68) 0.64 1.19 (0.75-1.89) 0.47 1.27 (0.85-1.89) 0.25
1Using metabolic syndrome variables. 2Using homeostasis model only. 3Dietary quality determined by DASH score. 4Median food pyramid compliance score. Figures are
expressed as OR (95%CI). Reference group is metabolically unhealthy within same BMI category. Each factor is adjusted for every other factor in the table.
doi: 10.1371/journal.pone.0076188.t005
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